Identification of Antisense RNA NRAS-AS and Its Preliminary Exploration of the Anticancer Regulatory Mechanism
Genes · 2024
DOI: 10.3390/genes15121524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Liping Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biobank, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Membrane Proteins, Cell Proliferation. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, The General projects of Jiangsu Science and technology plan, The General project of medical scientific research of Jiangsu Provincial Health Commission.
Abstract (Originalsprache)
Objective
To explore the influence of NRAS-AS on the proliferation, apoptosis, cell cycle, migration, and invasion ability of HCC cells, as well as its underlying mechanisms.
Methods
A double-stranded cDNA library for liver cancer cells was constructed, and identified NRAS-AS through High-throughput sequencing, bioinformatics, chain-specific fluorescent quantitative PCR, and RACE. NRAS-AS′s effects on HepG2 and SMMC-7721 cells and gene expression were evaluated. Additionally, the study analyzed the influence of NRAS-AS overexpression on tumor formation in nude mice. Immunohistochemistry and Western blotting were used to detect NRAS protein levels in clinical samples. RT-qPCR examined NRAS-AS and NRAS gene expression in HCC and adjacent tissues.
Results
NRAS-AS overexpression suppresses HCC cell proliferation and invasion, induces cell cycle alterations in HepG2 and SMMC-7721 cells, and enhances apoptosis. NRAS-AS interference promoted liver cancer invasion, inhibited apoptosis, and influences the cell cycle. Nude mice overexpressing NRAS-AS showed smaller tumors. NRAS-AS expression in liver cancer patients correlated with clinical factors. RT-qPCR revealed an inverse correlation between NRAS-AS and NRAS gene expression in liver cancer and adjacent tissues. IHC analysis revealed reduced NRAS protein expression in HepG2 and SMMC-7721 cells following NRAS-AS overexpression. The impact of AZA treatment on antisense NRAS-AS and sense NRAS gene expression in liver cancer cells was observed, and antisense.
Conclusion
Reduced NRAS-AS expression is frequently observed in HCC and is inversely related to NRAS gene expression, suggesting a role in HCC pathogenesis through NRAS regulation. Targeting antisense RNA NRAS-AS could hold promise as a therapeutic target and diagnostic biomarker for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biobank, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, China.
- College of Animal Science and Technology, Institute of Epigenetics and Epigenomics, Yangzhou University, Yangzhou 225001, China.
- Jiangsu Key Laboratory for Animal Genetic, Breeding and Molecular Design, College of Animal Science and Technology, Yangzhou University, Yangzhou 225001, China.
- School of Nursing School of Public Health, Yangzhou University, Yangzhou 225001, China.
- Clinical Pharmacist, Foothills Medical Centre, 140329 St NW, Calgary, AB T2N 2T9, Canada.
ORCID-Profile: Xuming Hu
Förderung
- The National Natural Science Foundation of China
- The General projects of Jiangsu Science and technology plan
- The General project of medical scientific research of Jiangsu Provincial Health Commission
Zitieren
APA
Wang, L., Hu, X., Tao, C., Xiang, J., & Cui, H. (2024). Identification of Antisense RNA NRAS-AS and Its Preliminary Exploration of the Anticancer Regulatory Mechanism. Genes. https://doi.org/10.3390/genes15121524
Vancouver
Wang L, Hu X, Tao C, Xiang J, Cui H. Identification of Antisense RNA NRAS-AS and Its Preliminary Exploration of the Anticancer Regulatory Mechanism. Genes. 2024. doi:10.3390/genes15121524
BibTeX
@article{Wang2024,
author = {Wang, Liping and Hu, Xuming and Tao, Chenyue and Xiang, Jacob and Cui, Hengmi},
title = {Identification of Antisense RNA NRAS-AS and Its Preliminary Exploration of the Anticancer Regulatory Mechanism},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15121524}
}
EUVIMED